openPR Logo
Press release

Preimplantation Genetic Diagnosis Market Research Report by Key Players Analysis 2020

12-27-2017 11:16 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Preimplantation Genetic Diagnosis Market Research Report

Transparency Market Research (TMR) has announced the publication of a new market research report on the preimplantation genetic diagnosis. Statistics mentioned in the report suggest that the global preimplantation genetic diagnosis market was valued at US$77.2 million in 2013 and is expected to reach US$118.0 million by 2020, growing a CAGR of 6.28% from 2014 to 2020. The report, titled “Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, offers an in-depth understanding of the global preimplantation genetic diagnosis market, its growth drivers, market restraints, and potential growth opportunities in the coming future.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html

According to market research report published by Transparency Market Research, the global preimplantation genetic diagnosis (PGD) market is witnessing stupendous growth due to rise of infertility, which leads to a delayed conception and a higher risk of genetic diseases. Reasons such as the desire to give birth to a disease-free offspring are pushing infertile patients to go through PGD cycle. The other factor driving the global preimplantation genetic diagnosis (PGD) market is the possibility of the offspring having a genetic predisposition to cardiac diseases and the capability of PGD to diagnose rare diseases such as fibrodysplasia ossificans progressive (FOP). The desire of the healthcare community to bring up a generation that is free of diseases is the primary reason for the growth of the global preimplantation genetic diagnosis (PGD) market.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=427

In terms of geography, Europe held the biggest market share, at over 50% in 2013. The alarming rate of infertility in Europe due to unhealthy lifestyle choices such as excessive alcohol intake, smoking, and substance abuse has made Europe the leading regional preimplantation genetic diagnosis market. Smoking excessively or for a long time can have serious repercussions on pregnancy. Smokers are at a much higher risk of giving birth to offspring with abnormalities. Such risks are prompting patients to opt for PGD as well.The aneuploidy screening test segment of the global preimplantation genetic diagnosis (PGD) market held a market share of 36% in 2013. This test is used for counting the number of chromosomes. It reduces the chances of transferring an embryo that may have a chromosomal abnormality. Additionally, liberal regulations in several countries permit PGD for aneuploidy screening and are thus adding to the growth prospects of aneuploidy screening.

Download Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=427

PGD for human leukocyte antigen (HLA typing) is also one of the rapidly growing test types in this market. This test is conducted on an embryo that is then tissue matched and donated to the stem cells of its ailing sibling. This test is a boon for children who have siblings suffering from X-linked adrenoleukodystrophy (X-ALD), sickle cell anemia, β-thalassaemia, and Fanconi anemia, and X-linked hypohidrotic ectodermal dysplasia with an immune deficiency (HED-ID). The growing incidences of these diseases and increasing awareness of HLA typing is also expected to boost its market share in the same period.

Some of the key players in the global preimplantation genetic diagnosis market are Genesis Genetics Ltd., Illumina, Inc., Genea Ltd., Natera, Inc., Laboratory Corporation of America Holdings, PerkinElmer, Inc., Reprogenetics, LLC, Quest Diagnostics, Inc., and Reproductive Genetics Institute.

Purchase this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=427<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preimplantation Genetic Diagnosis Market Research Report by Key Players Analysis 2020 here

News-ID: 877060 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for PGD

Preimplantation Genetics Diagnosis (PGD) Market Key Findings, Growth Strategy, T …
Preimplantation Genetics Diagnosis (PGD) Market - Overview The size of the preimplantation genetics diagnosis (PGD) market has been estimated to grow at a significant speed in the forthcoming years. This rapid growth in the market is on the basis of the high accuracy of the PGD in order to detect genetic disorders. In addition to this, increasing investment to detect genetic disorders along with chromosomal abnormalities around the world is also
Preimplantation Genetics Diagnosis (PGD) Market Current Scenario Trends, Compreh …
Preimplantation Genetics Diagnosis (PGD) Market - Overview The size of the preimplantation genetics diagnosis (PGD) market has been estimated to grow at a significant speed in the forthcoming years. This rapid growth in the market is on the basis of the high accuracy of the PGD in order to detect genetic disorders. In addition to this, increasing investment to detect genetic disorders along with chromosomal abnormalities around the world is also
Preimplantation Genetics Diagnosis (PGD) Market: Increasing Demand for Efficient …
The world PGD market is expected to witness notable growth in the coming years owning to the rising prevalence of genetic, hereditary and chromosomal diseases. Moreover, PGD have high chances of conceiving healthy embryos. However, the high costs incurred in the PGD technologies hamper the growth of the market. Moreover, stringent government regulations and ethical concerns also obstruct the growth of the market. In coming years, there would be increase
01-20-2020 | Health & Medicine
CRIFAX
Preimplantation Genetic Diagnosis (PGD) Market – Industry Growth Analysis & Fo …
CRIFAX added a report on ‘Preimplantation Genetic Diagnosis (PGD) Market Analysis Report, Global Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Netherlands, Russia, China, India, Japan, Australia, South Korea, Malaysia, Brazil, Mexico, Argentina, GCC, South Africa), Growth Potential, Competitive Market Share & Forecast, 2019 – 2028’to its database of market research collaterals consisting of overall market scenario with prevalent and future growth prospects, among other growth strategies used by key
Global Preimplantation Genetic Diagnosis (PGD) Market is Anticipated to Reach US …
A new Transparency Market Research report states that the global preimplantation genetic diagnosis (PGD) market stood at US$77.2 mn in 2013 and is anticipated to reach US$118 mn by 2020, by expanding at a CAGR of 6.28% from 2014 to 2020. The title of the report is “Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.” Preimplantation genetic diagnosis (PGD) is the genetic
Global Preimplantation Genetic Diagnosis Market (PGD) to Reach $121.50 Million b …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Preimplantation Genetic Diagnosis Market “ Get Free Sample Report @ https://www.mrrse.com/sample/1351 Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader